Development, validity and responsiveness of the clinical COPD questionnaire

Health and Quality of Life Outcomes

Volumn 1, Issue , 2003, Pages

  van der Molen, Thys ^a,d   Willemse, Brigitte W M ^b   Schokker, Siebrig ^a   ten Hacken, Nick H T ^b   Postma, Dirkje S ^b   Juniper, Elizabeth F ^c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL PRACTICE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; QUALITATIVE ANALYSIS; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SMOKING CESSATION; SMOKING HABIT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; VALIDATION PROCESS; CLASSIFICATION; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; HOSPITALIZATION; LONGITUDINAL STUDY; MIDDLE AGED; NETHERLANDS; QUALITY OF LIFE; REPRODUCIBILITY; SICKNESS IMPACT PROFILE; VALIDATION STUDY;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE;

EID: 1842552108     PISSN: 14777525     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7525-1-13     Document Type: Article

References (16)

1. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, Yernault JC, Decramer M, Higenbottam T, Postma DS and Rees J Optimal assessment and management of chronic obstructive pulmonary disease (COPD): a consensus statement of the European Respiratory Society Eur Respir J 1995, 8:1398-1420
2. Murray CLJ and Lopez AD Alternative projection of mortality and disability by cause 1990 - 2020: global burden of disease study Lancet 1997, 394:1498-1504
3. Feenstra TL, van Genugten ML, Hoogenveen RT, Wouters EF and Rutten-van Molken MP The impact of aging and smoking on the future of chronic obstructive pulmonary disease: a model analysis in the Netherlands Am J Respir Crit Care Med 2001, 164:590-596
4. Jones PW, Quirk FH, Baveystock CM and Littlejohns P A self-complete measure of chronic airflow limitation - the St George Respiratory Questionnaire Am Rev Respir Dis 1992, 145:1321-1327
5. Guyatt GH, Berman LB, Townsend M, Pugsley SO and Chambers LW A measure of quality of life for clinical trials in chronic lung disease Thorax 1987, 42:773-778
6. Maille AR, Koning CJ, Zwinderman AH, Willems LN, Dijkman JH and Kaptein AA The development of the Quality of life for Respiratory Illness questionnaire (QOL-RIQ): a disease-specific quality of life questionnaire for patients with mild to moderate chronic non-specific lung disease Respir Med 1997, 91:297-309
7. Donohue JF, van Noord JA, Bateman ED, Langley SJ, Lee A, Witek TJ, Kesten S and Towse L A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol Chest 2002, 122(1):47-55
8. Wijkstra PJ, Van Altena R, Kraan J, Otten V, Postma DS and Koeter GH Quality of life in patients with chronic obstructive pulmonary disease improves after rehabilitation at home Eur Respir J 1994, 7(2):269-73
9. Spencer S, Calverly PM, Sherwood-Burge P and Jones PW Health Status deteriration in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 2001, 163(1):122-8
10. Jones PW Issues concerning health-related quality of life in COPD Chest 1995, 107:187s-193s
11. Pauwels RA, Buist AS, Calverley PM, Jenkins CR and Hurd SS the GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary Am J Respir Crit Care Med 2001, 163(5):1256-1276
12. Juniper EF, Guyatt GH and Jaeschke R How to develop and validate a new quality of life instrument In: Quality of Life and Pharmacoeconomics in Clinical Trials (Edited by: Spilker B) Raven Press Ltd, New York 1995, 49-56
13. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ and King DR Development and validation of a questionnaire to measure asthma control Eur Respir J 1999, 14:902-907
14. Ware JJ and Sherbourne CD The MOS 36-item short form health survey (SF-36): I. Conceptual framework and item selection Med Care 1992, 30:473-483
15. Jones PW Quality of life measurement for patients with diseases of the airways Thorax 1991, 46:676-682
16. 1decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study Am J Respir Crit Care Med 2001, 164:358-364